Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-007415
Filing Date
2022-02-23
Accepted
2022-02-23 17:30:41
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4124
  Complete submission text file 0000899243-22-007415.txt   5580
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address COMPASS THERAPEUTICS, INC. 80 GUEST ST., SUITE 601 BOSTON MA 02135
Business Address
Kalled Susan (Reporting) CIK: 0001860504 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39696 | Film No.: 22665188